Piscataway, NJ (PRWEB) February 18, 2015
This year marks a quarter century that the New Jersey Center for Biomaterials will host the region’s most prestigious biomaterials event, The New Jersey Symposium on Biomaterials Science. Since its inception, the event has grown in size and prestige to achieve an international reputation. In recognition of the importance of the event, the Planning Committee for the NJ Symposium on Biomaterials Science has put together an outstanding array of speakers to address the attendees at the forthcoming event in November. An array of distinguished scholars and scientists will come together to discuss topics ranging from pure research to clinical trials to translation of biomaterials applications. These renowned researchers from academia, industry, and the clinical arena will focus on topical sessions that will have direct application to the biomaterials and pharmacological industries. Because of this level of focus and detail, attendees are assured of finding value in the Symposium.
The goal of the Symposium series is to exchange information and ideas across the full spectrum of scientists who are working in the biomaterials field. Through their focus on research and development topics that represent the most current and promising directions to ultimately permit medical applications, science can translate what is learned in the laboratory to help those individuals who have suffered wounds and severe trauma to regain their lives.
Registration for the 2015 NJ Symposium on Biomaterials Science is available at http://tinyurl.com/Biomat-Syposium-2015
The New Jersey Center for Biomaterials (NJCBM) was founded in 1997. Based at Rutgers, the State University of New Jersey, the center spans academia, industry and government. Staffed by biomaterial scientists, the Center works to improve health care and quality of life by developing advanced biomedical products for tissue repair and replacement as well as the delivery of pharmaceutical agents. The Center’s technologies have been translated into clinical and pre-clinical products including surgical meshes, cardiovascular stents, bone regeneration scaffolds, and ocular drug delivery systems.
Related Biomaterials Press Releases